ep ahead factor line
ep ahead consensu adj ep
exceed view stronger revenu off-set weaker
profit factor line includ lower interest expens tax rate
share count predominantli drove beat ad revis
initi ep target midpoint vs
previou midpoint rais ep
reflect latest upsid better top-line trend
exceed view pharmaci comp acceler vs
higher volum attribut part strategi
pull prescript network chang dynam improv
agreement matur name prime relationship retail pharmaci
trend continu drag continu anem front-end
comp gross margin fell bp new pharmaci relationship bp
plan administr cost fell anoth bp bp lower
plan repres continu partial off-set ebitda margin
declin bp yoy bp plan produc cash flow
million help fund share repurchas acquisit
reiter outperform rate cleanest beat
encourag latest top-line upsid profit pressur somewhat
anticip new network relationship new ep guidanc move
higher beat excl benefit tax reform view
potenti meaning wba broader network strategi track
nice help contribut step pharmaci volume market share
bp yoy cost cut continu off-set associ margin pressur
drive cash flow quarter continu dynam view
ep contribut like modest acquir dec
materi synergi contribut allow continu upsid longer
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
walgreen co togeth subsidiari oper drugstor
chain unit state compani provid custom
multichannel access consum good servic
pharmaci health well servic commun across
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
cash-flow financ activ
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
better fundament perform sentiment could drive upsid
target price blue sky scenario
weaker fundament perform sentiment could lead
downsid versu target price grey sky scenario
 close
compani mention price
